DK3638807T3 - MIRNA-574-5p som biomarkør til stratificering af prostaglandin E-afhængige tumorer - Google Patents
MIRNA-574-5p som biomarkør til stratificering af prostaglandin E-afhængige tumorer Download PDFInfo
- Publication number
- DK3638807T3 DK3638807T3 DK18728664.6T DK18728664T DK3638807T3 DK 3638807 T3 DK3638807 T3 DK 3638807T3 DK 18728664 T DK18728664 T DK 18728664T DK 3638807 T3 DK3638807 T3 DK 3638807T3
- Authority
- DK
- Denmark
- Prior art keywords
- mirna
- prostaglandin
- biomarker
- stratification
- dependent tumors
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 title 1
- 238000013517 stratification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17175535 | 2017-06-12 | ||
| PCT/EP2018/065318 WO2018228978A1 (en) | 2017-06-12 | 2018-06-11 | Mirna-574-5p as a biomarker for stratification of prostaglandin e-dependent tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3638807T3 true DK3638807T3 (da) | 2022-06-27 |
Family
ID=59054023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18728664.6T DK3638807T3 (da) | 2017-06-12 | 2018-06-11 | MIRNA-574-5p som biomarkør til stratificering af prostaglandin E-afhængige tumorer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200123620A1 (da) |
| EP (1) | EP3638807B1 (da) |
| JP (1) | JP7171712B2 (da) |
| KR (1) | KR102726586B1 (da) |
| CN (1) | CN110785500A (da) |
| CA (1) | CA3067069C (da) |
| DK (1) | DK3638807T3 (da) |
| ES (1) | ES2911253T3 (da) |
| WO (1) | WO2018228978A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113376386B (zh) * | 2020-03-09 | 2025-09-02 | 中国科学院广州生物医药与健康研究院 | 一种病毒性肺炎的标志物及其应用 |
| WO2023152568A2 (en) * | 2022-02-10 | 2023-08-17 | Oslo Universitetssykehus Hf | Compositions and methods for characterizing lung cancer |
| EP4613860A1 (en) * | 2024-03-07 | 2025-09-10 | Technische Universität Darmstadt | Inhibitors of mir-574-5p for use in intra-articular treatment of osteoarthritis and other related arthritic diseases |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2692973A1 (en) * | 2007-07-12 | 2009-01-15 | Tragara Pharmaceuticals, Inc. | Patient selection and therapeutic methods using markers of prostaglandin metabolism |
| CA2800557A1 (en) * | 2010-04-29 | 2011-11-03 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy |
| WO2011146937A1 (en) * | 2010-05-21 | 2011-11-24 | The Translational Genomics Research Institute | Methods and kits useful in diagnosing nsclc |
| WO2013082624A2 (en) * | 2011-12-01 | 2013-06-06 | The Ohio State University | Materials and methods related to nsaid chemoprevention in colorectal cancer |
| TWI568722B (zh) * | 2012-06-15 | 2017-02-01 | 葛蘭馬克製藥公司 | 作爲mPGES-1抑制劑之三唑酮化合物 |
-
2018
- 2018-06-11 DK DK18728664.6T patent/DK3638807T3/da active
- 2018-06-11 ES ES18728664T patent/ES2911253T3/es active Active
- 2018-06-11 CN CN201880039282.2A patent/CN110785500A/zh active Pending
- 2018-06-11 WO PCT/EP2018/065318 patent/WO2018228978A1/en not_active Ceased
- 2018-06-11 CA CA3067069A patent/CA3067069C/en active Active
- 2018-06-11 JP JP2020518576A patent/JP7171712B2/ja active Active
- 2018-06-11 KR KR1020197038690A patent/KR102726586B1/ko active Active
- 2018-06-11 EP EP18728664.6A patent/EP3638807B1/en active Active
- 2018-06-11 US US16/621,683 patent/US20200123620A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3638807A1 (en) | 2020-04-22 |
| WO2018228978A1 (en) | 2018-12-20 |
| EP3638807B1 (en) | 2022-03-30 |
| CN110785500A (zh) | 2020-02-11 |
| CA3067069C (en) | 2023-04-04 |
| ES2911253T3 (es) | 2022-05-18 |
| JP7171712B2 (ja) | 2022-11-15 |
| JP2020523039A (ja) | 2020-08-06 |
| CA3067069A1 (en) | 2018-12-20 |
| US20200123620A1 (en) | 2020-04-23 |
| KR102726586B1 (ko) | 2024-11-05 |
| KR20200018508A (ko) | 2020-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR24C1009I2 (fr) | Composés utilisés comme inhibiteurs de kinase | |
| DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK3788040T3 (da) | Pyridazinoner som parp7-inhibitorer | |
| DK3656769T3 (da) | Aryl-phosphor-oxygen-forbindelse som egfr-kinase-inhibitor | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3292123T3 (da) | Faste former af en forbindelse, der modulerer kinaser | |
| EP3515957A4 (en) | RENEWABLE BIOLOGICAL HIGH-PERFORMANCE POLYESTER POLYOLS | |
| DK3303348T3 (da) | Naphthyridinforbindelser som JAK-kinaseinhibitorer | |
| GEAP201914379A (en) | Heteroaryl compounds for kinase inhibition | |
| DK3066085T3 (da) | Fremgangsmåde til syntesen af en indolamin-2,3-dioxygenaseinhibitor | |
| DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
| DK3372584T3 (da) | Fremgangsmåde til fremstillingen af en diarylthiohydantoin-forbindelse | |
| DK3239134T3 (da) | Pyridonamider som modulatorer af natriumkanaler | |
| DK3998070T3 (da) | Mir-124 som biomarkør til behandling af inflammatoriske sygdomme | |
| EP3316910A4 (en) | UPPER TRIPLET TRIPLET ANNIHILATION UPWARD IMPLEMENTATION | |
| DK3152176T5 (da) | Fremgangsmåde til fremstillingen af en cementforbindelse | |
| DK3831833T3 (da) | Fremgangsmåder til fremstillingen af en pi3k-inhibitor | |
| DK3692039T3 (da) | Enantiomerer af substituerede thiazoler som antivirale forbindelser | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3717488T3 (da) | Substituerede furanopyrimidinforbindelser som pde1-inhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer |